Profound Medical closes $6.45M private placement of 921,428 shares at $7.00 each

Profound Medical Corp.

Issued 921,428 common shares at US$7.00 per share to Canadian investors for gross proceeds of ~US$6.45M.
Proceeds to be used for sales and marketing expansion, working capital, R&D, strategic transactions, and general corporate purposes.
Shares subject to four-month-plus-one-day hold period under Canadian securities laws.
Company to file resale registration statement with SEC within four months of closing.
Offering closed on December 30, 2025, under Regulation S exemption from U.S. registration.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Profound Medical Corp. entered into Subscription Agreement with certain Canadian investors valued at aggregate gross proceeds of $6.45 million (effective 2025-12-30).

Action: entry
Agreement: equity purchase
Counterparty: certain Canadian investors
Value: aggregate gross proceeds of $6.45 million
Effective: 2025-12-30

Exact text from the filing

On December 30, 2025, Profound Medical Corp. (the “Company”) entered into a subscription agreement (the “Subscription Agreement”) with certain Canadian investors (the “Investors”) providing for the private placement of an aggregate of 921,428 shares of the Company’s common shares (the “Shares”), at a per share purchase price of $7.00 (the “Offering”) for aggregate gross proceeds of $6.45 million.

View on SEC.gov

290 material agreements filed in the last 30 days. Browse all material agreements →

Profound Medical Corp. filing history →

Source: SEC EDGAR

accession 0001104659-25-125344

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.